Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
Surg Endosc
.
2025 Jan;39(1):180-183.
doi: 10.1007/s00464-024-11263-2.
Epub 2024 Oct 29.
Authors
Tammy L Kindel
1
,
Andrew Y Wang
2
,
Anupama Wadhwa
3
4
,
Allison R Schulman
5
,
Reem Z Sharaiha
6
,
Matthew Kroh
7
,
Omar M Ghanem
8
,
Shauna Levy
9
,
Girish P Joshi
3
,
Teresa LaMasters
10
;
Representing the American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, American Society of Anesthesiologists, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons
Affiliations
1
Department of Surgery, Medical College of Wisconsin, 8700 Watertown Plank Road, Milwaukee, WI, 53226, USA. tkindel@mcw.edu.
2
Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA.
3
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, TX, USA.
4
Outcomes Research Consortium, University of Texas, Houston, USA.
5
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
6
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
7
Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.
8
Department of Surgery, Mayo Clinic, Rochester, MN, USA.
9
Department of Surgery, Tulane University, New Orleans, LA, USA.
10
Medical Director UnityPoint Clinic Weight Loss Specialists, University of Iowa, West Des Moines, IA, USA.
PMID:
39370500
PMCID:
PMC11666732
DOI:
10.1007/s00464-024-11263-2
No abstract available